Differentiation of human follicular thyroid adenomas from carcinomas by gene expression profiling

Oncology Reports

Volumn 19, Issue 2, 2008, Pages 329-337

  Zhao, Jianming ^a   Leonard, Christa ^a   Gemsenjäger, Ernst ^b   Heitz, Philipp U ^a   Moch, Holger ^a   Odermatt, Bernhard ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b Hospital of Zollikerberg   (Switzerland)

Author keywords

cDNA array; Follicular thyroid adenoma; Follicular thyroid carcinoma; Gene expression profiling

Indexed keywords

BINDING PROTEIN; CARRIER PROTEIN; CELL ADHESION MOLECULE; COMPLEMENTARY DNA; GENE PRODUCT; MEMBRANE PROTEIN; MOLECULAR MARKER; NUCLEAR PROTEIN; REGULATOR PROTEIN; SCLEROPROTEIN; TRANSCRIPTION FACTOR;

ADULT; AGED; ARTICLE; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; DNA MICROARRAY; FEMALE; FOLLICULAR CARCINOMA; GENE EXPRESSION PROFILING; GENETIC IDENTIFICATION; GENETIC VARIABILITY; HUMAN; HUMAN TISSUE; MALE; MALIGNANT TRANSFORMATION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SIGNAL NOISE RATIO; SIGNAL TRANSDUCTION; THYROID ADENOMA; THYROID CARCINOMA; THYROID TUMOR; TUMOR DIFFERENTIATION; UNINDEXED SEQUENCE;

EID: 38749126362     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.19.2.329     Document Type: Article

References (31)

1. Hundahl SA, Fleming ID, Fremgen AM and Menck HR: A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995. Cancer 83: 2638-2648, 1998.
2. Parkin DM, Bray F, Ferlay J and Pisani P: Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108, 2005.
3. Mazzaferri EL: Management of a solitary thyroid nodule. N Engl J Med 328: 553-559, 1993.
4. Gharib H: Fine-needle aspiration biopsy of thyroid nodules: advantages, limitations, and effect. Mayo Clin Proc 69: 44-49, 1994.
5. Gharib H, Goellner JR and Johnson DA: Fine-needle aspiration cytology of the thyroid. A 12-year experience with 11,000 biopsies. Clin Lab Med 13: 699-709, 1993.
6. Goellner JR, Gharib H, Grant CS and Johnson DA: Fine needle aspiration cytology of the thyroid, 1980 to 1986. Acta Cytol 31: 587-590, 1987.
7. Ravetto C, Colombo L and Dottorini ME: Usefulness of fine-needle aspiration in the diagnosis of thyroid carcinoma: a retrospective study in 37,895 patients. Cancer 90: 357-363, 2000.
8. Baloch ZW, Fleisher S, LiVolsi VA and Gupta PK: Diagnosis of 'follicular neoplasm': a gray zone in thyroid fine-needle aspiration cytology. Diagn Cytopathol 26: 41-44, 2002.
9. Yang GC, Liebeskind D and Messina AV: Should cytopathologists stop reporting follicular neoplasms on fine-needle aspiration of the thyroid? Cancer 99: 69-74, 2003.
10. Kroll TG, Sarraf P, Pecciarini L, Chen CJ, Mueller E, Spiegelman BM and Fletcher JA: PAX8-PPARgammal fusion oncogene in human thyroid carcinoma. Science 289: 1357-1360, 2000.
11. Inohara H, Honjo Y, Yoshii T, Akahani S, Yoshida J, Hattori K, Okamoto S, Sawada T, Raz A and Kubo T: Expression of galectin-3 in fine-needle aspirates as a diagnostic marker differentiating benign from malignant thyroid neoplasms. Cancer 85: 2475-2484, 1999.
12. Bartolazzi A, Gasbarri A, Papotti M, Bussolati G, Lucante T, Khan A, Inohara H, Marandino F, Orlandi F, Nardi F, Vecchione A, Tecce R and Larsson O: Application of an immunodiagnostic method for improving preoperative diagnosis of nodular thyroid lesions. Lancet 357: 1644-1650, 2001.
13. Marques AR, Espadinha C, Catarino AL, Moniz S, Pereira T, Sobrinho LG and Leite V: Expression of PAX8-PPAR gamma 1 rearrangements in both follicular thyroid carcinomas and adenomas. J Clin Endocrinol Metab 87: 3947-3952, 2002.
14. Cheung L, Messina M, Gill A, Clarkson A, Learoyd D, Delbridge L, Wentworth J, Philips J, Clifton-Bligh R and Robinson BG: Detection of the PAX8-PPAR gamma fusion oncogene in both follicular thyroid carcinomas and adenomas. J Clin Endocrinol Metab 88: 354-357, 2003.
15. Martins L, Matsuo SE, Ebina KN, Kulcsar MA, Friguglietti CU and Kimura ET: Galectin-3 messenger ribonucleic acid and protein are expressed in benign thyroid tumors. J Clin Endocrinol Metab 87: 4806-4810, 2002.
16. Mehrotra P, Okpokam A, Bouhaidar R, Johnson SJ, Wilson JA, Davies BR and Lennard TW: Galectin-3 does not reliably distinguish benign from malignant thyroid neoplasms. Histopathology 45: 493-500, 2004.
17. Mills LJ, Poller DN and Yiangou C: Galectin-3 is not useful in thyroid FNA. Cytopathology 16: 132-138, 2005.
18. Barden CB, Shister KW, Zhu B, Guiter G, Greenblatt DY, Zeiger MA and Fahey TJ III: Classification of follicular thyroid tumors by molecular signature: results of gene profiling. Clin Cancer Res 9: 1792-1800, 2003.
19. Mazzanti C, Zeiger MA, Costourous N, Umbricht C, Westra WH, Smith D, Somervell H, Bevilacqua G, Alexander HR and Libutti SK: Using gene expression profiling to differentiate benign versus malignant thyroid tumors. Cancer Res 64: 2898-2903, 2004.
20. Weber F, Shen L, Aldred MA, Morrison CD, Frilling A, Saji M, Schuppert F, Broelsch CE, Ringel MD and Eng C: Genetic classification of benign and malignant thyroid follicular neoplasia based on a three-gene combination. J Clin Endocrinol Metab 90: 2512-2521,2005.
21. Lubitz CC, Gallagher LA, Finley DJ, Zhu B and Fahey TJ III: Molecular analysis of minimally invasive follicular carcinomas by gene profiling. Surgery 138: 1042-1048, 2005.
22. Fryknas M, Wickenberg-Bolin U, Goransson H, Gustafsson MG, Foukakis T, Lee JJ, Landegren U, Hoog A, Larsson C, Grimelius L, Wallin G, Pettersson U and Isaksson A: Molecular markers for discrimination of benign and malignant follicular thyroid tumors. Tumour Biol 27:211-220, 2006.
23. Stolf BS, Santos MM, Simao DF, Diaz JP, Cristo EB, Hirata R, Jr., Curado MP, Neves EJ, Kowalski LP and Carvalho AF: Class distinction between follicular adenomas and follicular carcinomas of the thyroid gland on the basis of their signature expression. Cancer 106: 1891-1900, 2006.
24. Delellis RA, Lloyd RV, Heitz PU and Eng C: World Health Organization Classification of Tumours: In: Pathology and Genetics of Tumours of Endocrine Organs. IARC Press, Lyon, 2004.
25. Zhao J, Leonard C, Brunner E, Gemsenjager E, Heitz PU and Odermatt B: Molecular characterization of well-differentiated human thyroid carcinomas by cDNA arrays. Int J Oncol 29: 1041-1051,2006.
26. Winzer R, Schmutzler C, Jakobs TC, Ebert R, Rendi J, Reiners C, Jakob F and Kohrle J: Reverse transcriptase-polymerase chain reaction analysis of thyrocyte-relevant genes in fine-needle aspiration biopsies of the human thyroid. Thyroid 8: 981-987, 1998.
27. Takano T, Miyauchi A, Matsuzuka F, Liu G, Higashiyama T, Yokozawa T, Kuma K and Amino N: Preoperative diagnosis of medullary thyroid carcinoma by RT-PCR using RNA extracted from leftover cells within a needle used for fine needle aspiration biopsy. J Clin Endocrinol Metab 84:951-955, 1999.
28. Aldred MA, Ginn-Pease ME, Morrison CD, Popkie AP, Gimm O, Hoang-Vu C, Krause U, Dralle H, Jhiang SM, Plass C and Eng C: Caveolin-1 and caveolin-2, together with three bone morphogenetic protein-related genes, may encode novel tumor suppressors down-regulated in sporadic follicular thyroid carcinogenesis. Cancer Res 63: 2864-2871, 2003.
29. Chevillard S, Ugolin N, Vielh P, Ory K, Levalois C, Elliott D, Clayman GL and El-Naggar AK: Gene expression profiling of differentiated thyroid neoplasms: diagnostic and clinical implications. Clin Cancer Res 10: 6586-6597, 2004.
30. Tan PK, Downey TJ, Spitznagel Jr EL, Xu P, Fu D, Dimitrov DS, Lempicki RA, Raaka BM and Cam MC: Evaluation of gene expression measurements from commercial microarray plafforms. Nucleic Acids Res 31: 5676-5684, 2003.
31. Jarvinen AK, Hautaniemi S, Edgren H, Auvinen P, Saarela J, Kallioniemi OP and Monni O: Are data from different gene expression microarray platforms comparable? Genomics 83: 1164-1168, 2004.